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Background: Glioblastoma is a type of brain tumor with poor response to available therapies, and shows high rate of mortality. Despite 
remarkable advancements in our knowledge about cytogenetic and pathophysiologic features of glioblastoma, current treatment 
strategies are mainly based on cytotoxic drugs; however, these therapeutic approaches are facing progressive failure because of the 
resistant nature of glioblastomas. In the recent years, however, promising results have emerged owing to targeted therapies toward 
molecular pathways within cancerous cells. Unfolded Protein Response (UPR) is a remarkable signaling pathway that triggers both 
apoptosis and survival pathways within cells, and therefore induces UPR-related apoptotic pathways in cancer cells by ER stress inducers.
Objectives: Recently, the role of Bee venom (Bv), which contains powerful bioactive peptides, in inducing UPR-related apoptosis was 
revealed in cancer cell lines. Nevertheless, currently there are no reports of Bv potential ability in induction of UPR apoptotic routes in 
glioblastoma. The aim of current study was to evaluate possible role of Bee venome in inducing of UPR pathway within A172 glioblastoma 
cell line.
Materials and Methods: We treated the A172 glioblastoma cell line with different Bv doses, and assessed UPR-related genes expression by 
real-time Polymerase Chain Reaction (PCR).
Results: The IC50 of Bv for the studied cell line was 28 μg/mL. Furthermore, we observed that Bv can induce UPR target genes (Grp94 and 
Gadd153) over-expression through a dose-dependent mechanism.
Conclusions: Our results suggest the potential role of Bv as a therapeutic agent for glioblastomas.
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1. Background
Glioblastoma is a deadly brain malignancy with pro-
gressive resistance to available therapies. Despite signifi-
cant molecular advancements in clinical research, our 
therapies against cancer still largely depend on general 
cytotoxic effects of drugs (1). As a result, many neoplastic 
conditions, which work in an invasive manner, will even-
tually acquire resistant against conventional therapies 
(2, 3). Recently, targeted therapies considering molecular 
adaptors of tumor cells have created promising opportu-
nities to fight progression of multiple tumors (3-5).
Unfolded Protein Response (UPR) signaling pathway 
is a survival/apoptotic pathway, which is activated upon 
Endoplasmic Reticulum (ER) stress. Unfolded Protein 
Response has been demonstrated to be able to induce 
powerful apoptotic routes in different cancerous cells 
including glioblastomas. Although multiple agents 
have been reported as UPR inducers within neoplastic 
glioblastoma cell lines (6-9), because of limitations in 
their toxicity level and effectiveness, their clinical use 
have had restrictions in many cases. Considering these 
issues, more investigations are required to identify 
new potential and applicable ER stress inducer agents. 
These potential agents would subsequently provide us 
with wider resources for developing new drugs in dif-
ferent forms of cancer.
Lately, anti-cancerous and anti-proliferative proper-
ties of Bee venom (Bv) have been disclosed by multiple 
investigations. These reports represent the great thera-
peutic potential of Bv as an effective agent in many can-
cers. Bee venom consists of powerful active peptides 
such as melittin and phospholipase A2 (PLA2). These 
molecules target multiple cancerous cell lines includ-
ing renal, lung, liver, prostate and bladder (10-15). Nev-
ertheless, the potential effects of Bv on glioblastoma 
have not been studied.
2. Objectives
Our aim was to evaluate the possible role of Bv in activa-
tion of UPR in the A172 glioblastoma cell line. 
Bazi A et al.
Biotech Health Sci. 2015;2(2):e275472
3. Materials and Methods
This study was carried out at the Avicena Research Insti-
tute of Mashhad University of Medical Sciences in 2014.
3.1. Cell Culture
A172 glioblastoma cell line (Pastor Institute, Iran) was cul-
tured in Roswell Park Memorial Institute (RPMI) 1640 me-
dium containing 10% Fetal Bovine Serum (FBS) (Gibco) and 
1% pen-strep (Biosera). Cells were grown at 37°C and 5% CO2.
3.2. Bee Venom Toxicity Determination
In order to determine Bv cytotoxicity, IC50 of the agent 
was determined through the methylthiazol tetrazolium 
(MTT) assay. Cells were seeded in a 96-plate and after 12 
hours, previously prepared Bv concentrations of 0, 5, 10, 
20, 40, 80, and 160 μg/mL were added to the plates. As a 
positive control, IC50 concentration of Cisplatin was de-
termined for the A172 cell line. Treated cells were incubat-
ed in 5% CO2 and 37°C for 24 and 48 hours. Next, 10 μL of 
MTT (5 mg/mL in PBS) was added to plates and incubation 
was continued for four hours in the dark. After this step, 
the supernatant of the cell culture was replaced with di-
methyl sulfoxide (DMSO), and light absorption was de-
termined at 540 nm using an Enzyme Linked Immuno-
sorbent Assay (ELISA) reader. The experiment was carried 
out in triplicates and IC50 concentration was calculated 
by the Graph pad prism v5 software.
3.3. RNA Extraction
We used the total RNA extraction kit (Parstous, Iran) 
to obtain cellular RNA. The experiment was performed 
according to the manufacturer’s instructions, and RNA 
quality was assessed by running the product on 1% aga-
rose gel.
3.4. cDNA Synthesis
cDNA was synthetized using a purchased kit (Parstous, 
Iran) according to the manufacturer’s instructions. Poly-
merase Chain Reaction (PCR) on housekeeping GAPDH 
gene was performed to confirm cDNA synthesis.
3.5. Real-Time Polymerase Chain Reaction
We measured the expression of the two major UPR tar-
get genes, Grp94 and Gadd153, via quantitative real time 
PCR. The employed primers had the following sequenc-
es: forward: 5’-TCGCCTCAGTTTGAACATTGAC-3’ and reverse: 5’-CTTCTGCTGTCTCTTCAGGTTCTTC-3’ for Grp94 and forward: 5’-TGGAAATGAAGAGGAAGAATCAAAA-3’ and reverse: 5’-CAGC-CAAGCCAGAGAAGCA-3’ for Gadd153. The reaction mixture 
to run the experiment included: 10 μL SYBR Green dye 
(Parstous), 1 μL mixed primer, 1 μL cDNA, 0.7 μL ROX dye, 
and 7.6 μL diluted water. The reaction was performed for 
40 cycles on Strategene Mx 3000 instrument at the de-
naturation phase (95, 30 seconds), annealing phase (60, 
30 seconds) and extension phase (72, 45 seconds). House-
keeping GAPDH gene was applied as the normalizer.
4. Results
4.1. IC50 of Bee Venome in A172 Cell Line
After 24 and 48-hour periods, 50% viability of cells in 
exposure to Bv was obtained as 28.53 and 28.30 μg/mL, 
respectively.
4.2. Bee Venom Induces Dose-Dependent Unfolded Protein Response Target Genes Expression
Expression of the two UPR target genes, Grp94 and 
Gadd153, was assessed at 0.1, 1 and 10 μg/mL Bv concen-
trations. Figure 1 shows the respective alternations in 
expression of Grp94 and Gadd153 genes in response to 
utilized Bv concentrations.
Figure 1. Unfolded Protein Response Target Genes Expression in Control 
(Untreated) and Bee Venom-Treated A172 Glioblastoma Cells
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A, Grp94; B, Gadd153. Fold changes have been demonstrated in various 
states. Both genes were overexpressed in Bv treated cells showing UPR in-
duction. Increased fold changes at 0.1, 1, and 10 μg/mL Bv concentrations 
were 1.5, 1.9, and 2.9 for Grp94 and 2, 2.1, and 1.5 for Gadd153 respectively. 
P for difference of two genes expression at different concentrations and 
control state was less than 0.05 (t-student test). However, difference be-
tween exposed groups was not significant.
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5. Discussion
Poor responsiveness to therapy and low overall sur-
vival rate of patients suffering from glioblastoma ne-
cessitates more extensive researches to provide new 
and targeted therapeutic protocols (3, 5). The resistant 
nature of this tumor against many conventional thera-
pies demonstrates the dynamic course of disease pro-
gression, which requires appropriate growth rate of 
related medications (4). In recent studies, molecular 
targets involved in apoptotic processes have created an 
opportunity to develop more effective drugs for cancer. 
In this regard, UPR-signaling pathway is an interesting 
area of investigations (6, 9, 16). Although relationships 
of Bv and different cellular apoptotic pathways have 
been described, UPR activation has been uncovered as 
an important mechanism of Bv impact on various tu-
mor cell lines (13). In the present research, we also ob-
served that UPR target genes, Grp94 and Gadd153, were 
overexpressed in a dose dependent manner by Bv treat-
ment of the glioblastoma cell line. Endoplasmic Retic-
ulum stress and UPR pathway participate in apoptotic 
death of glioblastoma cell lines exposed to anti-tumor 
agents such as berberine (16) and cannabinoid (17). In-
terestingly, ER stress has sensitized several drug-resis-
tant glioblastoma cell lines to radio (18) and chemo (19) 
based therapeutic approaches. Therefore, UPR activa-
tion in A172 glioblastoma cell lines by Bv can also result 
in apoptosis initiation in cancerous cells. As we found in 
the current study, elevated doses of Bv caused stronger 
target genes expression indicating the potential capac-
ity of Bv to be used in dose-coordinated trials.
Regarding difficulties in managing of glioblastoma 
and its current poor prognosis, development of new 
generation-targeted therapies seems to be urgent. In 
the current study, we found that Bv can induce dose-de-
pendent UPR signaling activation in A172 glioblastoma 
cell line. Therefore, we suggest that Bv and its derivative 
bioactive peptides could play important roles in future 
UPR-based therapeutic approaches for glioblastoma.
Acknowledgements
We appreciate Mashhad University of Medical Sciences 
for their financial support.
Authors’ Contributions
Study concept and design: Ali Bazi. Acquisition of data: 
Ali Bazi, Mohsen Sisakht and Mehran Gholamin. Analysis 
and interpretation of data: Ali Bazi, Mohsen Sisakht and 
Mehran Gholamin. Drafting of the manuscript: Ali Bazi. 
Critical revision of the manuscript for important intel-
lectual content: Mohammad Reza Keramati. Statistical 
analysis: Ali Bazi, Mohsen Sisakht. Administrative, tech-
nical, and material support: Mehran Gholamin, Moham-
mad Reza Keramati.
Funding/Support
This study was financially supported by Mashhad Uni-
versity of Medical Sciences.
References
1.       Omuro A, DeAngelis LM. Glioblastoma and other malignant glio-
mas: a clinical review. JAMA. 2013;310(17):1842–50.
2.       Bielamowicz K, Khawja S, Ahmed N. Adoptive cell therapies for 
glioblastoma. Front Oncol. 2013;3:275.
3.       Weathers SP, Gilbert MR. Advances in treating glioblastoma. F1000Prime Rep. 2014;6:46.
4.       Carlsson SK, Brothers SP, Wahlestedt C. Emerging treatment 
strategies for glioblastoma multiforme. EMBO Mol Med. 
2014;6(11):1359–70.
5.       Reardon DA, Wen PY. Therapeutic advances in the treatment of 
glioblastoma: rationale and potential role of targeted agents. Oncologist. 2006;11(2):152–64.
6.       Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, et 
al. Aggravated endoplasmic reticulum stress as a basis for en-
hanced glioblastoma cell killing by bortezomib in combination 
with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res. 2008;68(3):843–51.
7.       Schonthal AH, Chen TC, Hofman FM, Louie SG, Petasis NA. Pre-
clinical development of novel anti-glioma drugs targeting 
the endoplasmic reticulum stress response. Curr Pharm Des. 
2011;17(23):2428–38.
8.       Proulx-Bonneau S, Pratt J, Annabi B. A role for MT1-MMP as a 
cell death sensor/effector through the regulation of endoplas-
mic reticulum stress in U87 glioblastoma cells. J Neurooncol. 
2011;104(1):33–43.
9.       Kavitha CV, Jain AK, Agarwal C, Pierce A, Keating A, Huber KM, et 
al. Asiatic acid induces endoplasmic reticulum stress and apop-
totic death in glioblastoma multiforme cells both in vitro and in 
vivo. Mol Carcinog. 2014.
10.       Park MH, Choi MS, Kwak DH, Oh KW, Yoon do Y, Han SB, et al. Anti-
cancer effect of bee venom in prostate cancer cells through ac-
tivation of caspase pathway via inactivation of NF-kappaB. Pros-tate. 2011;71(8):801–12.
11.       Hong SJ, Rim GS, Yang HI, Yin CS, Koh HG, Jang MH, et al. Bee 
venom induces apoptosis through caspase-3 activation in syno-
vial fibroblasts of patients with rheumatoid arthritis. Toxicon. 
2005;46(1):39–45.
12.       Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, et al. Anti-can-
cer effect of bee venom toxin and melittin in ovarian cancer cells 
through induction of death receptors and inhibition of JAK2/
STAT3 pathway. Toxicol Appl Pharmacol. 2012;258(1):72–81.
13.       Orsolic N. Bee venom in cancer therapy. Cancer Metastasis Rev. 
2012;31(1-2):173–94.
14.       Ip SW, Chu YL, Yu CS, Chen PY, Ho HC, Yang JS, et al. Bee venom 
induces apoptosis through intracellular Ca2+ -modulated in-
trinsic death pathway in human bladder cancer cells. Int J Urol. 
2012;19(1):61–70.
15.       Ip SW, Wei HC, Lin JP, Kuo HM, Liu KC, Hsu SC, et al. Bee venom 
induced cell cycle arrest and apoptosis in human cervical epider-
moid carcinoma Ca Ski cells. Anticancer Res. 2008;28(2A):833–42.
16.       Eom KS, Kim HJ, So HS, Park R, Kim TY. Berberine-induced apop-
tosis in human glioblastoma T98G cells is mediated by endoplas-
mic reticulum stress accompanying reactive oxygen species and 
mitochondrial dysfunction. Biol Pharm Bull. 2010;33(10):1644–9.
17.       Ellert-Miklaszewska A, Ciechomska I, Kaminska B. Cannabinoid 
signaling in glioma cells. Adv Exp Med Biol. 2013;986:209–20.
18.       Suzuki K, Gerelchuluun A, Hong Z, Sun L, Zenkoh J, Moritake T, 
et al. Celecoxib enhances radiosensitivity of hypoxic glioblas-
toma cells through endoplasmic reticulum stress. Neuro Oncol. 
2013;15(9):1186–99.
19.       Lee D, Sun S, Ho AS, Kiang KM, Zhang XQ, Xu FF, et al. Hyper-
oxia resensitizes chemoresistant glioblastoma cells to temo-
zolomide through unfolded protein response. Anticancer Res. 
2014;34(6):2957–66.
